Cargando…

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use

Background and Aims: All-oral interferon-free antivirals are highly effective in treating recurrent hepatitis C (HCV) infection in liver transplant (LT) recipients. The aim of the study was to assess immunosuppression needs after achieving a sustained viral response (SVR). Methods: We compared immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saab, Sammy, Rheem, Justin, Jimenez, Melissa, Bau, Sherona, Choi, Gina, Durazo, Francisco, El Kabany, Mohammed, Han, Steven, Farid, Alexander, Jamal, Naadir, Grotts, Jonathan, Elashoff, David, Busuttil, Ronald W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807141/ https://www.ncbi.nlm.nih.gov/pubmed/27047770 http://dx.doi.org/10.14218/JCTH.2016.00001

Ejemplares similares

Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
por: Saab, Sammy, et al.
Publicado: (2017)

Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States
por: Saab, Sammy, et al.
Publicado: (2016)

Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018)

Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2017)

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
por: Aby, Elizabeth, et al.
Publicado: (2017)

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals
por: Nguyen, Kelvin, et al.
Publicado: (2017)

Transjugular Liver Biopsy: Safe Even in Patients With Severe Coagulopathies and Multiple Biopsies
por: Sue, Megan J., et al.
Publicado: (2019)

Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience
por: Sheen, Victoria, et al.
Publicado: (2016)

Limited Knowledge of Acetaminophen in Patients with Liver Disease
por: Saab, Sammy, et al.
Publicado: (2016)

De novo Hepatocellular Carcinoma after Liver Transplantation
por: Saab, Sammy, et al.
Publicado: (2015)

COVID-19 in Liver Transplant Recipients
por: Kullar, Ravina, et al.
Publicado: (2021)

Coil-Assisted Retrograde Transvenous Obliteration (CARTO) for the Treatment of Portal Hypertensive Variceal Bleeding: Preliminary Results
por: Lee, Edward W, et al.
Publicado: (2014)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients in Korea
por: Lee, Jee Hyun, et al.
Publicado: (2009)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Covid-19 in kidney transplant recipients with immunosuppressive therapy
por: Sheikhalipour, Zahra, et al.
Publicado: (2022)

Accuracy and Safety of 1,055 Transjugular Liver Biopsies in Postliver Transplant Patients
por: Lee, Edward Wolfgang, et al.
Publicado: (2021)

Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
por: Toapanta, Néstor, et al.
Publicado: (2022)

Depression in Nonclassical Hypogonadism in Young Men
por: Korenman, Stanley G, et al.
Publicado: (2018)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
por: Anton Pampols, Paula, et al.
Publicado: (2021)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
por: Zilberg, Catherine, et al.
Publicado: (2022)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Massive Necrotizing Pancreatitis in an Immunosuppressed Renal Transplant Recipient (Successful Therapy)
por: Slaton, Joel W., et al.
Publicado: (1993)

Neutropenic Enterocolitis in a Pediatric Heart Transplant Recipient on Multiple Immunosuppressants
por: Miller, Emily E., et al.
Publicado: (2018)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
por: Liu, Fu-Chao, et al.
Publicado: (2017)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020)

188 COVID-19 and Kidney Transplant Recipients: Immunosuppression Management and Outcomes
Publicado: (2021)

Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients
por: Kwiatkowska, Marlena, et al.
Publicado: (2021)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Pacemaker-related Candida parapsilosis fungaemia in an immunosuppressed renal transplant recipient
por: Hebert, Josephine, et al.
Publicado: (2021)

Follow-Up Factors Contribute to Immunosuppressant Adherence in Kidney Transplant Recipients
por: Chen, Tingting, et al.
Publicado: (2022)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy
por: Kolla, Epiphane, et al.
Publicado: (2023)

Risk of Graft Failure in Kidney Recipients with Cured Post-Transplant Cancer
por: Kim, Ji Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_34pgpp9dopnt8p9karnlf6tta1